C73
BillableMalignant neoplasm of thyroid gland
HCC Category Mapping
What This Code Means
Cancer that develops in the thyroid gland, a butterfly-shaped gland in the neck that produces hormones regulating metabolism.
Coding Tips
- •This code does not differentiate between histological types (papillary, follicular, medullary, anaplastic); review pathology reports for histology if needed for treatment planning
- •Ensure documentation specifies thyroid gland involvement and not metastatic disease to the thyroid from another primary site
Clinical Significance
Malignant neoplasm of the thyroid gland is one of the more common endocrine malignancies, with papillary thyroid carcinoma being the most prevalent subtype. Despite generally favorable prognosis for well-differentiated types, this diagnosis carries meaningful risk adjustment weight and requires lifelong surveillance with thyroid function monitoring and cancer recurrence screening. Accurate coding distinguishes active malignancy from personal history of thyroid cancer.
Documentation Requirements
- ✓Pathology report confirming malignancy with histological type (papillary, follicular, medullary, anaplastic, or poorly differentiated)
- ✓Current status — active disease vs. in remission vs. history of (Z85.850 for personal history)
- ✓Staging information (TNM staging) when available
- ✓Treatment status — post-thyroidectomy, radioactive iodine therapy, current surveillance
- ✓Thyroglobulin levels and thyroid function tests supporting ongoing monitoring
Use Additional Code
- code to identify any functional activity